Access to artemisinin combination therapy for malaria in remote areas of Cambodia
-
* Corresponding author: Shunmay Yeung shunmay@tropmedres.ac
Malaria Journal 2008, 7:96 doi:10.1186/1475-2875-7-96
Accesses
- Last 30 days: 160 accesses
- Last year: 1611 accesses
- All time: 7045 accesses
Cited by
BioMed Central: 13 citations
|
Research
Poor quality vital anti-malarials in Africa - an urgent neglected public health priority Paul N Newton, Michael D Green, Dallas C Mildenhall, Aline Plançon, Henry Nettey, Leonard Nyadong, Dana M Hostetler, Isabel Swamidoss, Glenn A Harris, Kristen Powell, Ans E Timmermans, Abdinasir A Amin, Stephen K Opuni, Serge Barbereau, Claude Faurant, Ray CW Soong, Kevin Faure, Jonarthan Thevanayagam, Peter Fernandes, Harparkash Kaur, Brian Angus, Kasia Stepniewska, Philippe J Guerin, Facundo M Fernández Malaria Journal 2011, 10:352 (13 December 2011) Criminals are producing diverse harmful anti-malarial counterfeits with important public health consequences. With the threatening spread of artemisinin resistance to Africa, much greater investment is required to ensure the quality of ACT and removal of artemisinin monotherapies.
|
|
Research
Megan Littrell, Hellen Gatakaa, Sochea Phok, Henrietta Allen, Shunmay Yeung, Char Chuor, Lek Dysoley, Duong Socheat, Angus Spiers, Chris White, Tanya Shewchuk, Desmond Chavasse, Kathryn A O'Connell Malaria Journal 2011, 10:328 (31 October 2011) This article is part of a collection on The ACTwatch project:... An interesting paper, reporting data from large surveys both at outlet and household level. While this data shows favourable progress towards replacing artemisinin monotherapies with ACT, the widespread use of drug cocktails to treat malaria is a barrier to effective case management.
|
|
Research
George Mtove, Ilse CE Hendriksen, Ben Amos, Hedwiga Mrema, Victor Mandia, Alphaxard Manjurano, Florida Muro, Alma Sykes, Helena Hildenwall, Christopher JM Whitty, Hugh Reyburn Malaria Journal 2011, 10:290 (6 October 2011) Use of RDTs to direct the use of anti-malarial drugs in young children did not result in any missed diagnoses of malaria although new infections soon after a consultation with a negative RDT result may undermine confidence in results.
|
|
Case study
Shunmay Yeung, Edith Patouillard, Henrietta Allen, Duong Socheat Malaria Journal 2011, 10:243 (18 August 2011) Although, Cambodia successfully artesunate-mefloquine since the early 2000s in public health facilities, several studies have shown that most people with fever do not seek treatment from government facilities, but that a big proportion of the population source anti-malarials through the private sector.
|
|
Research
Methods for evaluating delivery systems for scaling-up malaria control intervention Jayne Webster, Daniel Chandramohan, Kara Hanson BMC Health Services Research 2010, 10(Suppl 1):S8 (2 July 2010) |
|
Research
Barriers to prompt and effective malaria treatment among the poorest population in Kenya Jane Chuma, Vincent Okungu, Catherine Molyneux Malaria Journal 2010, 9:144 (27 May 2010) Evidence suggests that the poorest populations benefit less from malaria control interventions, and are less likely to seek prompt and effective treatment.
|
|
Research
Junko Yasuoka, Krishna C Poudel, Kalpana Poudel-Tandukar, Chea Nguon, Po Ly, Duong Socheat, Masamine Jimba Malaria Journal 2010, 9:109 (23 April 2010) Currently, the activities of village malaria workers is focused primarily on diagnosis and treatment. The study suggests that their knowledge base needs substantial improvement and that the focus of their activity needs to be broadened in order to further strengthen community-based malaria control.
|
|
Research
Michael Hawkes, Jean Katsuva, Claude K Masumbuko Malaria Journal 2009, 8:308 (23 December 2009) This article provides an interesting description of feasibility and results of scaling up to provide rapid diagnosis of malaria in a difficult, war-torn setting. It is unique in this respect.
|
|
Research
Access to malaria treatment in young children of rural Burkina Faso Maike Tipke, Valérie R Louis, Maurice Yé, Manuela De Allegri, Claudia Beiersmann, Ali Sié, Olaf Mueller, Albrecht Jahn Malaria Journal 2009, 8:266 (24 November 2009) This deals with a subject of great relevance for malaria control in Africa, the need to increase access to anti-malarial treatment through community health works and home-treatment.
|
|
Research
Sivong Sengaloundeth, Michael D Green, Facundo M Fernández, Ot Manolin, Khamlieng Phommavong, Vongsavanh Insixiengmay, Christina Y Hampton, Leonard Nyadong, Dallas C Mildenhall, Dana Hostetler, Lamphet Khounsaknalath, Latsamy Vongsack, Samlane Phompida, Viengxay Vanisaveth, Lamphone Syhakhang, Paul N Newton Malaria Journal 2009, 8:172 (28 July 2009) An original and interesting piece of work that attempts to fill a gap in knowledge with regards to both research methodology in counterfeit drugs and the problem of artemisinin monotherapy. The results are very concerning and have important policy implications.
|
|
Review
The last man standing is the most resistant: eliminating artemisinin-resistant malaria in Cambodia Richard J Maude, Wirichada Pontavornpinyo, Sompob Saralamba, Ricardo Aguas, Shunmay Yeung, Arjen M Dondorp, Nicholas PJ Day, Nicholas J White, Lisa J White Malaria Journal 2009, 8:31 (20 February 2009) The authors use mathematical models to investigate possible consequences of various strategies to control the spread of artemisinin-resistance in the Thai-Cambodian border region.
|
|
Review
Deployment of ACT antimalarials for treatment of malaria: challenges and opportunities Christopher JM Whitty, Clare Chandler, Evelyn Ansah, Toby Leslie, Sarah G Staedke Malaria Journal 2008, 7(Suppl 1):S7 (11 December 2008) |
|
Research
Cost of increasing access to artemisinin combination therapy: the Cambodian experience Shunmay Yeung, Wim Van Damme, Duong Socheat, Nicholas J White, Anne Mills Malaria Journal 2008, 7:84 (20 May 2008) An interesting paper that presents financial costs associated with two distinct interventions to improve access to ACTs in Cambodia. The authors conclude that in addition to the costs of the drugs themselves, substantial investment may be needed to ensure that they affordably reach those most in need of them.
|